-+ 0.00%
-+ 0.00%
-+ 0.00%

The Zhitong Finance App learned that according to data exclusively provided by medical research company 3 Axis Advisors, pharmaceutical companies plan to increase the prices of at least 350 branded drugs in the US, including vaccines against COVID, respiratory syncytial virus, and shingles, as well as Ibrance, a major cancer treatment. The move comes at a time when the Trump administration is pressuring him to cut prices.

Zhitongcaijing·12/31/2025 13:33:16
Listen to the news
The Zhitong Finance App learned that according to data exclusively provided by medical research company 3 Axis Advisors, pharmaceutical companies plan to increase the prices of at least 350 branded drugs in the US, including vaccines against COVID, respiratory syncytial virus, and shingles, as well as Ibrance, a major cancer treatment. The move comes at a time when the Trump administration is pressuring him to cut prices.